3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
14
Leukemia, Myeloid, Acute
7
Neoplasms
3
Neoplasm Metastasis
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Neuroblastoma
2
Liver Neoplasms
2
Hepatoblastoma
2
Fibrolamellar hepatocellular carcinoma
2
Tongue Neoplasms
1
Thyroid cancer, Hurthle cell
1
Thyroid Diseases
1
Sarcoma, Myeloid
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors
1
Melanoma
1
Gastrointestinal Stromal Tumors
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
pembrolizumab
6
Cetuximab
5
olaparib
3
atezolizumab
3
Injections
3
fludarabine
2
Trastuzumab
2
Docetaxel
2
Cyclophosphamide
2
Bevacizumab
2
zimberelimab
1
zansecimab
1
tocilizumab
1
taxane
1
spartalizumab
1
somatostatin receptor 2
1
ribociclib
1
pralsetinib
1
pertuzumab
1
pegylated granulocyte colony-stimulating factor
1
lenvatinib
1
ipatasertib
1
inavolisib
1
fludarabine phosphate
1
entrectinib
1
encorafenib
1
durvalumab
1
dapagliflozin
1
cemiplimab
1
brigimadlin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumors
×
Sorafenib
×
1 year
×
Clear all
No trials found.